Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study.

MLA

Goletti D, et al. “Response to M. Tuberculosis Selected RD1 Peptides in Ugandan HIV-Infected Patients with Smear Positive Pulmonary Tuberculosis: A Pilot Study.” BMC Infectious Diseases, vol. 8, no. 1, Jan. 2008, p. 11. EBSCOhost, https://doi.org/10.1186/1471-2334-8-11.

APA

Goletti D, Carrara S, Mayanja-Kizza H, Baseke J, Mugerwa MA, Girardi E, Toossi Z, Goletti, D., Carrara, S., Mayanja-Kizza, H., Baseke, J., Mugerwa, M. A., Girardi, E., & Toossi, Z. (2008). Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study. BMC Infectious Diseases, 8(1), 11. https://doi.org/10.1186/1471-2334-8-11

Chicago

Goletti D, Carrara S, Mayanja-Kizza H, Baseke J, Mugerwa MA, Girardi E, Toossi Z, et al. 2008. “Response to M. Tuberculosis Selected RD1 Peptides in Ugandan HIV-Infected Patients with Smear Positive Pulmonary Tuberculosis: A Pilot Study.” BMC Infectious Diseases 8 (1): 11. doi:10.1186/1471-2334-8-11.